nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Electrocardiogram ST segment depression—Salbutamol—chronic obstructive pulmonary disease	0.0374	0.0407	CcSEcCtD
Propericiazine—Cardiac fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.0325	0.0354	CcSEcCtD
Propericiazine—Ileus paralytic—Tiotropium—chronic obstructive pulmonary disease	0.0258	0.028	CcSEcCtD
Propericiazine—Traumatic liver injury—Montelukast—chronic obstructive pulmonary disease	0.0236	0.0257	CcSEcCtD
Propericiazine—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.0159	0.0172	CcSEcCtD
Propericiazine—Respiratory depression—Aminophylline—chronic obstructive pulmonary disease	0.0157	0.0171	CcSEcCtD
Propericiazine—Pulmonary function test decreased—Aminophylline—chronic obstructive pulmonary disease	0.0157	0.0171	CcSEcCtD
Propericiazine—Glaucoma—Tiotropium—chronic obstructive pulmonary disease	0.0148	0.0161	CcSEcCtD
Propericiazine—Glaucoma—Formoterol—chronic obstructive pulmonary disease	0.0119	0.013	CcSEcCtD
Propericiazine—Glaucoma—Arformoterol—chronic obstructive pulmonary disease	0.0119	0.013	CcSEcCtD
Propericiazine—Ventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.0111	0.0121	CcSEcCtD
Propericiazine—Pigmentation disorder—Prednisone—chronic obstructive pulmonary disease	0.0106	0.0115	CcSEcCtD
Propericiazine—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.0105	0.0114	CcSEcCtD
Propericiazine—Aggression—Montelukast—chronic obstructive pulmonary disease	0.01	0.0109	CcSEcCtD
Propericiazine—Pneumonia—Roflumilast—chronic obstructive pulmonary disease	0.00997	0.0108	CcSEcCtD
Propericiazine—Aggression—Salbutamol—chronic obstructive pulmonary disease	0.00966	0.0105	CcSEcCtD
Propericiazine—Embolism venous—Prednisolone—chronic obstructive pulmonary disease	0.00965	0.0105	CcSEcCtD
Propericiazine—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.00927	0.0101	CcSEcCtD
Propericiazine—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.00927	0.0101	CcSEcCtD
Propericiazine—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.0088	0.00956	CcSEcCtD
Propericiazine—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00826	0.00898	CcSEcCtD
Propericiazine—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00781	0.00849	CcSEcCtD
Propericiazine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00726	0.00789	CcSEcCtD
Propericiazine—Nasal congestion—Formoterol—chronic obstructive pulmonary disease	0.00717	0.00779	CcSEcCtD
Propericiazine—Nasal congestion—Arformoterol—chronic obstructive pulmonary disease	0.00717	0.00779	CcSEcCtD
Propericiazine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00708	0.00769	CcSEcCtD
Propericiazine—Embolism venous—Prednisone—chronic obstructive pulmonary disease	0.00701	0.00762	CcSEcCtD
Propericiazine—Nasal congestion—Salbutamol—chronic obstructive pulmonary disease	0.00677	0.00736	CcSEcCtD
Propericiazine—Hyperglycaemia—Aminophylline—chronic obstructive pulmonary disease	0.00669	0.00727	CcSEcCtD
Propericiazine—Increased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00656	0.00713	CcSEcCtD
Propericiazine—Glaucoma—Prednisolone—chronic obstructive pulmonary disease	0.00647	0.00703	CcSEcCtD
Propericiazine—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.00639	0.00695	CcSEcCtD
Propericiazine—Hyperglycaemia—Tiotropium—chronic obstructive pulmonary disease	0.00631	0.00686	CcSEcCtD
Propericiazine—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00628	0.00683	CcSEcCtD
Propericiazine—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00594	0.00646	CcSEcCtD
Propericiazine—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00594	0.00646	CcSEcCtD
Propericiazine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00572	0.00622	CcSEcCtD
Propericiazine—Asthma—Formoterol—chronic obstructive pulmonary disease	0.00564	0.00613	CcSEcCtD
Propericiazine—Asthma—Arformoterol—chronic obstructive pulmonary disease	0.00564	0.00613	CcSEcCtD
Propericiazine—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00561	0.0061	CcSEcCtD
Propericiazine—Asthma—Montelukast—chronic obstructive pulmonary disease	0.00553	0.00601	CcSEcCtD
Propericiazine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00547	0.00595	CcSEcCtD
Propericiazine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00541	0.00588	CcSEcCtD
Propericiazine—Asthma—Salbutamol—chronic obstructive pulmonary disease	0.00533	0.00579	CcSEcCtD
Propericiazine—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.0053	0.00576	CcSEcCtD
Propericiazine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00519	0.00564	CcSEcCtD
Propericiazine—Hyperglycaemia—Arformoterol—chronic obstructive pulmonary disease	0.00509	0.00553	CcSEcCtD
Propericiazine—Hyperglycaemia—Formoterol—chronic obstructive pulmonary disease	0.00509	0.00553	CcSEcCtD
Propericiazine—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.005	0.00543	CcSEcCtD
Propericiazine—Pneumonia—Montelukast—chronic obstructive pulmonary disease	0.00496	0.00539	CcSEcCtD
Propericiazine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00493	0.00536	CcSEcCtD
Propericiazine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00484	0.00526	CcSEcCtD
Propericiazine—Hyperglycaemia—Salbutamol—chronic obstructive pulmonary disease	0.00481	0.00522	CcSEcCtD
Propericiazine—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.0048	0.00522	CcSEcCtD
Propericiazine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00475	0.00516	CcSEcCtD
Propericiazine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00475	0.00516	CcSEcCtD
Propericiazine—Glaucoma—Prednisone—chronic obstructive pulmonary disease	0.0047	0.00511	CcSEcCtD
Propericiazine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00466	0.00506	CcSEcCtD
Propericiazine—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00463	0.00503	CcSEcCtD
Propericiazine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00459	0.00499	CcSEcCtD
Propericiazine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00445	0.00484	CcSEcCtD
Propericiazine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00433	0.0047	CcSEcCtD
Propericiazine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00419	0.00456	CcSEcCtD
Propericiazine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00419	0.00456	CcSEcCtD
Propericiazine—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00419	0.00455	CcSEcCtD
Propericiazine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00411	0.00447	CcSEcCtD
Propericiazine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00411	0.00446	CcSEcCtD
Propericiazine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00406	0.00441	CcSEcCtD
Propericiazine—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00403	0.00439	CcSEcCtD
Propericiazine—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00403	0.00439	CcSEcCtD
Propericiazine—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.00403	0.00438	CcSEcCtD
Propericiazine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00402	0.00437	CcSEcCtD
Propericiazine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00399	0.00433	CcSEcCtD
Propericiazine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00398	0.00433	CcSEcCtD
Propericiazine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00398	0.00432	CcSEcCtD
Propericiazine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00396	0.0043	CcSEcCtD
Propericiazine—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00395	0.00429	CcSEcCtD
Propericiazine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00394	0.00428	CcSEcCtD
Propericiazine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00388	0.00422	CcSEcCtD
Propericiazine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00381	0.00415	CcSEcCtD
Propericiazine—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00381	0.00414	CcSEcCtD
Propericiazine—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	0.00376	0.00409	CcSEcCtD
Propericiazine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00376	0.00408	CcSEcCtD
Propericiazine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00368	0.004	CcSEcCtD
Propericiazine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00368	0.004	CcSEcCtD
Propericiazine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00361	0.00393	CcSEcCtD
Propericiazine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00361	0.00393	CcSEcCtD
Propericiazine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00361	0.00392	CcSEcCtD
Propericiazine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.0036	0.00391	CcSEcCtD
Propericiazine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00359	0.00391	CcSEcCtD
Propericiazine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00359	0.00391	CcSEcCtD
Propericiazine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00354	0.00385	CcSEcCtD
Propericiazine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00352	0.00383	CcSEcCtD
Propericiazine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00348	0.00378	CcSEcCtD
Propericiazine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00341	0.00371	CcSEcCtD
Propericiazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.0034	0.0037	CcSEcCtD
Propericiazine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00339	0.00369	CcSEcCtD
Propericiazine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00333	0.00362	CcSEcCtD
Propericiazine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00327	0.00356	CcSEcCtD
Propericiazine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00327	0.00356	CcSEcCtD
Propericiazine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00321	0.00349	CcSEcCtD
Propericiazine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00321	0.00349	CcSEcCtD
Propericiazine—Infection—Formoterol—chronic obstructive pulmonary disease	0.00319	0.00347	CcSEcCtD
Propericiazine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00319	0.00347	CcSEcCtD
Propericiazine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00314	0.00342	CcSEcCtD
Propericiazine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00313	0.0034	CcSEcCtD
Propericiazine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00313	0.0034	CcSEcCtD
Propericiazine—Infection—Montelukast—chronic obstructive pulmonary disease	0.00312	0.00339	CcSEcCtD
Propericiazine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00311	0.00338	CcSEcCtD
Propericiazine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00309	0.00336	CcSEcCtD
Propericiazine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00303	0.00329	CcSEcCtD
Propericiazine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00301	0.00327	CcSEcCtD
Propericiazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.003	0.00326	CcSEcCtD
Propericiazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.003	0.00326	CcSEcCtD
Propericiazine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00298	0.00324	CcSEcCtD
Propericiazine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00296	0.00321	CcSEcCtD
Propericiazine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00293	0.00318	CcSEcCtD
Propericiazine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00293	0.00318	CcSEcCtD
Propericiazine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.0029	0.00315	CcSEcCtD
Propericiazine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.0029	0.00315	CcSEcCtD
Propericiazine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00288	0.00314	CcSEcCtD
Propericiazine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00286	0.00311	CcSEcCtD
Propericiazine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00286	0.00311	CcSEcCtD
Propericiazine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00285	0.0031	CcSEcCtD
Propericiazine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00285	0.0031	CcSEcCtD
Propericiazine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00284	0.00309	CcSEcCtD
Propericiazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00283	0.00308	CcSEcCtD
Propericiazine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00279	0.00304	CcSEcCtD
Propericiazine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00278	0.00302	CcSEcCtD
Propericiazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00274	0.00298	CcSEcCtD
Propericiazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00274	0.00298	CcSEcCtD
Propericiazine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.00298	CcSEcCtD
Propericiazine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.00273	0.00297	CcSEcCtD
Propericiazine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.0027	0.00294	CcSEcCtD
Propericiazine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00269	0.00293	CcSEcCtD
Propericiazine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00268	0.00291	CcSEcCtD
Propericiazine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00266	0.00289	CcSEcCtD
Propericiazine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00266	0.00289	CcSEcCtD
Propericiazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00259	0.00282	CcSEcCtD
Propericiazine—ADRA1B—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	0.00254	0.0694	CbGpPWpGaD
Propericiazine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00254	0.00276	CcSEcCtD
Propericiazine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00254	0.00276	CcSEcCtD
Propericiazine—Clomipramine—GSTP1—chronic obstructive pulmonary disease	0.00253	0.0582	CrCbGaD
Propericiazine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00253	0.00275	CcSEcCtD
Propericiazine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00251	0.00273	CcSEcCtD
Propericiazine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.0025	0.00272	CcSEcCtD
Propericiazine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0025	0.00272	CcSEcCtD
Propericiazine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00248	0.0027	CcSEcCtD
Propericiazine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00239	0.0026	CcSEcCtD
Propericiazine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00236	0.00257	CcSEcCtD
Propericiazine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00236	0.00257	CcSEcCtD
Propericiazine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00236	0.00257	CcSEcCtD
Propericiazine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00234	0.00254	CcSEcCtD
Propericiazine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00232	0.00252	CcSEcCtD
Propericiazine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00223	0.00243	CcSEcCtD
Propericiazine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00239	CcSEcCtD
Propericiazine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00239	CcSEcCtD
Propericiazine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00218	0.00238	CcSEcCtD
Propericiazine—Domperidone—CYP1A2—chronic obstructive pulmonary disease	0.00217	0.0499	CrCbGaD
Propericiazine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00216	0.00235	CcSEcCtD
Propericiazine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00234	CcSEcCtD
Propericiazine—Cyamemazine—HTR2A—chronic obstructive pulmonary disease	0.00213	0.049	CrCbGaD
Propericiazine—ADRA2A—Adrenoceptors—ADRB2—chronic obstructive pulmonary disease	0.0021	0.0573	CbGpPWpGaD
Propericiazine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00225	CcSEcCtD
Propericiazine—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00205	0.00222	CcSEcCtD
Propericiazine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00222	CcSEcCtD
Propericiazine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00222	CcSEcCtD
Propericiazine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00202	0.0022	CcSEcCtD
Propericiazine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.0022	CcSEcCtD
Propericiazine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00202	0.0022	CcSEcCtD
Propericiazine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.0022	CcSEcCtD
Propericiazine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00202	0.0022	CcSEcCtD
Propericiazine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00201	0.00218	CcSEcCtD
Propericiazine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.002	0.00218	CcSEcCtD
Propericiazine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.002	0.00217	CcSEcCtD
Propericiazine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00198	0.00215	CcSEcCtD
Propericiazine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00198	0.00215	CcSEcCtD
Propericiazine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00195	0.00212	CcSEcCtD
Propericiazine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00209	CcSEcCtD
Propericiazine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00208	CcSEcCtD
Propericiazine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.00207	CcSEcCtD
Propericiazine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00207	CcSEcCtD
Propericiazine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00207	CcSEcCtD
Propericiazine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00187	0.00203	CcSEcCtD
Propericiazine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00196	CcSEcCtD
Propericiazine—ADRA2A—Platelet Aggregation (Plug Formation)—RAPGEF3—chronic obstructive pulmonary disease	0.00177	0.0483	CbGpPWpGaD
Propericiazine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00174	0.00189	CcSEcCtD
Propericiazine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.0017	0.00184	CcSEcCtD
Propericiazine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00168	0.00183	CcSEcCtD
Propericiazine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00159	0.00173	CcSEcCtD
Propericiazine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00157	0.00171	CcSEcCtD
Propericiazine—Thiothixene—CYP1A2—chronic obstructive pulmonary disease	0.00156	0.0359	CrCbGaD
Propericiazine—Pipotiazine—CYP1A2—chronic obstructive pulmonary disease	0.00156	0.0359	CrCbGaD
Propericiazine—Zuclopenthixol—HTR2A—chronic obstructive pulmonary disease	0.00153	0.0351	CrCbGaD
Propericiazine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00159	CcSEcCtD
Propericiazine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00155	CcSEcCtD
Propericiazine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00154	CcSEcCtD
Propericiazine—Acepromazine—HTR2A—chronic obstructive pulmonary disease	0.00137	0.0315	CrCbGaD
Propericiazine—Clomipramine—SLC6A4—chronic obstructive pulmonary disease	0.00136	0.0312	CrCbGaD
Propericiazine—Fluphenazine—CYP1A2—chronic obstructive pulmonary disease	0.00135	0.031	CrCbGaD
Propericiazine—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	0.00134	0.0308	CrCbGaD
Propericiazine—Pipotiazine—HTR2A—chronic obstructive pulmonary disease	0.00132	0.0303	CrCbGaD
Propericiazine—Thiothixene—HTR2A—chronic obstructive pulmonary disease	0.00132	0.0303	CrCbGaD
Propericiazine—Mesoridazine—HTR2A—chronic obstructive pulmonary disease	0.0013	0.0299	CrCbGaD
Propericiazine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00139	CcSEcCtD
Propericiazine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00126	0.00137	CcSEcCtD
Propericiazine—Infection—Prednisone—chronic obstructive pulmonary disease	0.00125	0.00136	CcSEcCtD
Propericiazine—Clomipramine—CYP1A2—chronic obstructive pulmonary disease	0.00124	0.0284	CrCbGaD
Propericiazine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00134	CcSEcCtD
Propericiazine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00133	CcSEcCtD
Propericiazine—Thioridazine—CYP1A2—chronic obstructive pulmonary disease	0.00116	0.0267	CrCbGaD
Propericiazine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00124	CcSEcCtD
Propericiazine—Fluphenazine—HTR2A—chronic obstructive pulmonary disease	0.00114	0.0262	CrCbGaD
Propericiazine—Methotrimeprazine—CYP1A2—chronic obstructive pulmonary disease	0.00111	0.0255	CrCbGaD
Propericiazine—DRD1—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.0011	0.03	CbGpPWpGaD
Propericiazine—Propiomazine—HTR2A—chronic obstructive pulmonary disease	0.0011	0.0252	CrCbGaD
Propericiazine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.0011	0.00119	CcSEcCtD
Propericiazine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00119	CcSEcCtD
Propericiazine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00117	CcSEcCtD
Propericiazine—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	0.00108	0.0248	CrCbGaD
Propericiazine—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.00107	0.0245	CrCbGaD
Propericiazine—Clomipramine—HTR2A—chronic obstructive pulmonary disease	0.00104	0.024	CrCbGaD
Propericiazine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00112	CcSEcCtD
Propericiazine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000998	0.00109	CcSEcCtD
Propericiazine—ADRA2A—Regulation of insulin secretion—RAPGEF3—chronic obstructive pulmonary disease	0.000984	0.0268	CbGpPWpGaD
Propericiazine—Thioridazine—HTR2A—chronic obstructive pulmonary disease	0.000982	0.0226	CrCbGaD
Propericiazine—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000963	0.0221	CrCbGaD
Propericiazine—Acepromazine—ALB—chronic obstructive pulmonary disease	0.000938	0.0216	CrCbGaD
Propericiazine—Methotrimeprazine—HTR2A—chronic obstructive pulmonary disease	0.000937	0.0215	CrCbGaD
Propericiazine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00093	0.00101	CcSEcCtD
Propericiazine—DRD1—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000924	0.0252	CbGpPWpGaD
Propericiazine—Promethazine—HTR2A—chronic obstructive pulmonary disease	0.000923	0.0212	CrCbGaD
Propericiazine—Thioproperazine—ALB—chronic obstructive pulmonary disease	0.000917	0.0211	CrCbGaD
Propericiazine—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	0.000911	0.0209	CrCbGaD
Propericiazine—Thiothixene—ALB—chronic obstructive pulmonary disease	0.000902	0.0207	CrCbGaD
Propericiazine—Pipotiazine—ALB—chronic obstructive pulmonary disease	0.000902	0.0207	CrCbGaD
Propericiazine—Perphenazine—HTR2A—chronic obstructive pulmonary disease	0.000901	0.0207	CrCbGaD
Propericiazine—ADRA1B—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.0009	0.0246	CbGpPWpGaD
Propericiazine—Quetiapine—HTR2A—chronic obstructive pulmonary disease	0.000884	0.0203	CrCbGaD
Propericiazine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000864	0.000939	CcSEcCtD
Propericiazine—DRD1—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000859	0.0234	CbGpPWpGaD
Propericiazine—Chlorpromazine—CYP1A2—chronic obstructive pulmonary disease	0.000847	0.0195	CrCbGaD
Propericiazine—Promazine—HTR2A—chronic obstructive pulmonary disease	0.000812	0.0187	CrCbGaD
Propericiazine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000803	0.000873	CcSEcCtD
Propericiazine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000796	0.000866	CcSEcCtD
Propericiazine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000795	0.000865	CcSEcCtD
Propericiazine—ADRA2A—Integration of energy metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000774	0.0211	CbGpPWpGaD
Propericiazine—ADRA1B—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000757	0.0206	CbGpPWpGaD
Propericiazine—DRD1—G alpha (s) signalling events—PDE4A—chronic obstructive pulmonary disease	0.000754	0.0206	CbGpPWpGaD
Propericiazine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00075	0.000815	CcSEcCtD
Propericiazine—ADRA2A—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.000743	0.0203	CbGpPWpGaD
Propericiazine—DRD1—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000722	0.0197	CbGpPWpGaD
Propericiazine—Chlorpromazine—HTR2A—chronic obstructive pulmonary disease	0.000715	0.0164	CrCbGaD
Propericiazine—Clomipramine—ALB—chronic obstructive pulmonary disease	0.000713	0.0164	CrCbGaD
Propericiazine—ADRA1B—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000704	0.0192	CbGpPWpGaD
Propericiazine—ADRA2A—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.000624	0.017	CbGpPWpGaD
Propericiazine—ADRA1B—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000591	0.0161	CbGpPWpGaD
Propericiazine—ADRA1B—AMPK Signaling—ADIPOQ—chronic obstructive pulmonary disease	0.000584	0.0159	CbGpPWpGaD
Propericiazine—ADRA2A—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.000581	0.0158	CbGpPWpGaD
Propericiazine—Chlorpromazine—ALB—chronic obstructive pulmonary disease	0.000489	0.0112	CrCbGaD
Propericiazine—ADRA2A—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000488	0.0133	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000423	0.0116	CbGpPWpGaD
Propericiazine—DRD1—G alpha (s) signalling events—ADRB2—chronic obstructive pulmonary disease	0.000381	0.0104	CbGpPWpGaD
Propericiazine—ADRA1B—AMPK Signaling—LEP—chronic obstructive pulmonary disease	0.000363	0.00989	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000338	0.00922	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.00033	0.009	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000303	0.00827	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000302	0.00823	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00029	0.0079	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000277	0.00755	CbGpPWpGaD
Propericiazine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000269	0.00735	CbGpPWpGaD
Propericiazine—ADRA1B—LPA receptor mediated events—CXCL8—chronic obstructive pulmonary disease	0.000256	0.00698	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00025	0.00681	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000246	0.00672	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000243	0.00663	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000237	0.00647	CbGpPWpGaD
Propericiazine—ADRA1B—LPA receptor mediated events—MMP9—chronic obstructive pulmonary disease	0.000231	0.00631	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000228	0.00623	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000221	0.00602	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000218	0.00595	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000212	0.00579	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.000211	0.00575	CbGpPWpGaD
Propericiazine—ADRA1B—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000201	0.00548	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000196	0.00534	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000188	0.00513	CbGpPWpGaD
Propericiazine—ADRA1B—LPA receptor mediated events—EGFR—chronic obstructive pulmonary disease	0.000187	0.0051	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000182	0.00496	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000181	0.00493	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000181	0.00493	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.00018	0.0049	CbGpPWpGaD
Propericiazine—ADRA1B—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000176	0.00479	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000175	0.00478	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000174	0.00474	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000166	0.00452	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000162	0.00443	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000157	0.00429	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000155	0.00422	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000149	0.00407	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000149	0.00406	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000148	0.00404	CbGpPWpGaD
Propericiazine—ADRA1B—AMPK Signaling—TP53—chronic obstructive pulmonary disease	0.000148	0.00403	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000148	0.00403	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000143	0.00391	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000142	0.00388	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.00014	0.00383	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000138	0.00378	CbGpPWpGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000136	0.0037	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000134	0.00364	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000133	0.00363	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000127	0.00346	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000125	0.00342	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000125	0.0034	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000124	0.00337	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000123	0.00335	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000122	0.00333	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000116	0.00317	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000115	0.00314	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000113	0.00309	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000113	0.00309	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000112	0.00306	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.00011	0.00299	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000109	0.00299	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000109	0.00296	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000108	0.00295	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000105	0.00285	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000102	0.00278	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000101	0.00276	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	9.75e-05	0.00266	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	9.6e-05	0.00262	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	9.49e-05	0.00259	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	9.35e-05	0.00255	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	9.27e-05	0.00253	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	9.25e-05	0.00252	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	9.23e-05	0.00252	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	8.96e-05	0.00245	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	8.86e-05	0.00242	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.85e-05	0.00241	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	8.79e-05	0.0024	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	8.78e-05	0.00239	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GC—chronic obstructive pulmonary disease	8.61e-05	0.00235	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	8.42e-05	0.0023	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	8.36e-05	0.00228	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	8.3e-05	0.00226	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8e-05	0.00218	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	7.82e-05	0.00213	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	7.68e-05	0.00209	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	7.65e-05	0.00209	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	7.46e-05	0.00204	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	7.4e-05	0.00202	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	7.31e-05	0.00199	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	7.19e-05	0.00196	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	7.1e-05	0.00194	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	7.09e-05	0.00194	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	7.03e-05	0.00192	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	6.99e-05	0.00191	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	6.79e-05	0.00185	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	6.69e-05	0.00182	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	6.68e-05	0.00182	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	6.4e-05	0.00175	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	6.36e-05	0.00174	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	6.35e-05	0.00173	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—MMP1—chronic obstructive pulmonary disease	6.28e-05	0.00171	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—PLAU—chronic obstructive pulmonary disease	6.17e-05	0.00168	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	6.11e-05	0.00167	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.93e-05	0.00162	CbGpPWpGaD
Propericiazine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	5.84e-05	0.00159	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.82e-05	0.00159	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.72e-05	0.00156	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NOS2—chronic obstructive pulmonary disease	5.66e-05	0.00155	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5.61e-05	0.00153	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	5.55e-05	0.00151	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.48e-05	0.00149	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.47e-05	0.00149	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	5.45e-05	0.00149	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	5.29e-05	0.00144	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.2e-05	0.00142	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	5.01e-05	0.00137	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.89e-05	0.00133	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.8e-05	0.00131	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	4.77e-05	0.0013	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	4.76e-05	0.0013	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.72e-05	0.00129	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.7e-05	0.00128	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	4.65e-05	0.00127	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	4.55e-05	0.00124	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.55e-05	0.00124	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.55e-05	0.00124	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.52e-05	0.00123	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.52e-05	0.00123	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.29e-05	0.00117	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	4.24e-05	0.00116	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	4.19e-05	0.00114	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.13e-05	0.00113	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4e-05	0.00109	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.91e-05	0.00107	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.78e-05	0.00103	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.75e-05	0.00102	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.75e-05	0.00102	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.72e-05	0.00102	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.44e-05	0.000937	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	3.43e-05	0.000936	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.41e-05	0.00093	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.3e-05	0.000902	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.28e-05	0.000895	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.28e-05	0.000895	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.26e-05	0.000889	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.21e-05	0.000877	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.09e-05	0.000844	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.07e-05	0.000838	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.07e-05	0.000838	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.05e-05	0.000832	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.01e-05	0.000821	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	3e-05	0.000817	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.84e-05	0.000775	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.84e-05	0.000773	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.81e-05	0.000766	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.79e-05	0.000761	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.69e-05	0.000733	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.55e-05	0.000696	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.53e-05	0.000691	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.51e-05	0.000684	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.5e-05	0.000681	CbGpPWpGaD
Propericiazine—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	2.48e-05	0.000676	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.39e-05	0.000653	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.32e-05	0.000632	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.3e-05	0.000628	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.28e-05	0.000623	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.22e-05	0.000605	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.06e-05	0.000562	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.05e-05	0.00056	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.03e-05	0.000553	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.96e-05	0.000534	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	1.93e-05	0.000527	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.93e-05	0.000526	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.87e-05	0.00051	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	1.85e-05	0.000504	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.83e-05	0.0005	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.69e-05	0.000462	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.66e-05	0.000453	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.65e-05	0.000449	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.62e-05	0.000441	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.58e-05	0.00043	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.54e-05	0.000421	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.51e-05	0.000412	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.5e-05	0.000409	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.48e-05	0.000404	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.37e-05	0.000374	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.35e-05	0.000368	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.3e-05	0.000355	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.24e-05	0.000339	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.24e-05	0.000338	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.24e-05	0.000337	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.21e-05	0.000331	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.14e-05	0.00031	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.11e-05	0.000303	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.02e-05	0.000278	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.02e-05	0.000278	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1e-05	0.000273	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.32e-06	0.000254	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.4e-06	0.000229	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.69e-06	0.00021	CbGpPWpGaD
